Hims & Hers Health, Inc. (HIMS) P/E Ratio History
UndervaluedTrading at 55.7x vs 5Y avg 89.2x · 43th percentile · Below historical baseline · Data 2024–2025
Loading P/E history...
P/E Ratio Analysis
As of September 24, 2026, Hims & Hers Health, Inc. (HIMS) trades at a price-to-earnings ratio of 55.7x, with a stock price of $28.39 and trailing twelve-month earnings per share of $-0.61.
The current P/E is 38% below its 5-year average of 89.2x. Over the past five years, HIMS's P/E has ranged from a low of 42.6x to a high of 263.9x, placing the current valuation at the 43th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.7x, HIMS trades at a 135% premium to its sector peers. The sector includes 225 companies with P/E ratios ranging from 0.0x to 167.0x.
Relative to the broader market, HIMS commands a significant premium over the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our HIMS DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
HIMS Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
HIMS P/E vs Peers
Digital Health and Care Delivery peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $5B | 27.1 | 0.52Best | -12% | |
| $143M | 28.1 | - | +125%Best | |
| $166B | 165.4 | - | -11% | |
| $169B | 10.9Lowest | 0.53 | +2% | |
| $1.1T | 50.2 | 1.74 | +96% | |
| $879M | 131.3 | - | - | |
| $1B | 38.9 | - | +104% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
HIMS Historical P/E Data (2024–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | Dec 31 2025 | $32.47 | $0.51 | 63.2x | -29% |
| FY2025 Q3 | - | $56.72 | $0.54 | 104.4x | +17% |
| FY2025 Q2 | Jun 30 2025 | $49.85 | $0.80 | 62.3x | -30% |
| FY2025 Q1 | Mar 31 2025 | $29.55 | $0.69 | 43.0x | -52% |
| FY2024 Q4 | - | $24.18 | $0.54 | 45.1x | -49% |
| FY2024 Q3 | Sep 30 2024 | $18.42 | $0.43 | 42.6x | -52% |
| FY2024 Q2 | Jun 30 2024 | $20.19 | $0.08 | 263.9x | +196% |
Average P/E for displayed period: 89.2x
HIMS Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
2+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
HIMS — Frequently Asked Questions
Quick answers to the most common questions about buying HIMS stock.
What is HIMS's P/E ratio?
Hims & Hers Health, Inc. (HIMS) trailing twelve-month P/E ratio is 55.7x, based on TTM diluted EPS of $-0.61. The 5-year average P/E is 89.2x and the historical range spans 42.6x to 263.9x.
Is HIMS stock overvalued or undervalued?
HIMS trades at 55.7x P/E, below its 5-year average of 89.2x. At the 43th percentile of its historical range (42.6x–263.9x), the stock is priced at a discount to its own history.
Is HIMS stock expensive?
No, HIMS is not expensive on a historical basis. The current P/E of 55.7x is below the 5-year average of 89.2x and sits at the 43th percentile of its valuation range.
What is HIMS's historical P/E range?
Over the past 5 years, HIMS's P/E ratio has ranged from 42.6x to 263.9x, with a median of 62.3x and an average of 89.2x. The current P/E of 55.7x places the stock at the 43th percentile of this range. Full historical data spans 2024–2025.
How does HIMS's P/E compare to the S&P 500?
HIMS trades at 55.7x P/E versus the S&P 500 median of 25.3x. The 120% premium to the market typically reflects higher expected earnings growth or quality.
How does HIMS's valuation compare to Healthcare peers?
Hims & Hers Health, Inc. P/E of 55.7x compares to the Healthcare sector median of 23.7x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is HIMS's PEG ratio?
HIMS PEG ratio is N/A, based on a P/E of 55.7x and EPS growth of -3.8%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is HIMS's earnings yield?
HIMS earnings yield is 1.80%, the inverse of its 55.7x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.